Financials
- Market Capitalization 4.29 B
- Employee 137
- Founded 2017
- CEO N/A
- Website www.tangotx.com
- Headquarter Delaware, United States
- FIGI BBG00WFDDRS0
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.18
Rapporto prezzo/fatturato
16.5
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1426 | VKTX Viking Therapeutics, Inc. - Common Stock | 37.97 USD | -0.39% | -9.29% | +28.71% | +21.50% | 4.41 B USD | ||
| 1436 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 25.49 USD | -0.04% | -2.52% | +19.50% | +15.44% | 4.36 B USD | ||
| 1450 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.73 USD | -3.73% | -7.54% | +11.26% | +160.87% | 4.27 B USD | ||
| 1529 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 33.29 USD | +0.03% | -9.19% | +8.97% | -8.22% | 3.89 B USD |